Emergent BioSolutions awarded BARDA contract to develop and manufacture Ebola antibodies July 22, 2015
Spero Therapeutics receives first milestone payment under Roche anti-infectives collaboration July 22, 2015
First-in-human trial of the postexposure tuberculosis vaccine H56:IC31 in healthy adults July 20, 2015
RSS